当前位置: X-MOL 学术Nature › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cancer immunotherapy: The dark side of PD-1 receptor inhibition
Nature ( IF 50.5 ) Pub Date : 2017-11-15 , DOI: 10.1038/nature24759
Aya Ludin 1 , Leonard I Zon 1, 2
Affiliation  

&NA; Inhibiting the protein PD‐1 can activate T cells that trigger immune responses against tumour cells. But it emerges that, in mice, this immunotherapy exacerbates a cancer that involves the T cells themselves. See Letter p.121

中文翻译:

癌症免疫疗法:PD-1受体抑制的阴暗面

&NA; 抑制蛋白质 PD-1 可以激活 T 细胞,引发针对肿瘤细胞的免疫反应。但事实表明,在小鼠中,这种免疫疗法会加剧涉及 T 细胞本身的癌症。参见信第 121 页
更新日期:2017-11-15
down
wechat
bug